Integrated transcriptomic and proteomic analyses revealed a dual mechanistic pathway underlying HDCA efficacy: (1) suppression of NF-κB-driven inflammatory cascades and (2) activation of interferon-stimulated gene 15 (ISG15)-dependent antiviral pathways. The gene discussed is NFKB1; the disease is pancreatic hypoplasia-diabetes-congenital heart disease syndrome.